Pharmaceutical chemistry and technology Books
Springer Nature Switzerland AG Proteinkinase Inhibitors
Book SynopsisThis book reviews the principles of design and examples of successful implementation of proteinkinase inhibitors (PKI), and offers a comprehensive and authoritative overview of the history and latest developments in the field. Chapters written by experts from industry and academia cover the function, structure and topology of Proteinkinases, molecular modelling, disclose how to achieve high level of selectivity for kinase inhibitors, and exploit kinase inhibitors for cancer treatment. Particular attention is given to Inhibitors of c-Jun N-terminal kinase 3, and to covalent Janus Kinase 3 Inhibitors. A case study on Receptor Tyrosine Kinases EGFR, VEGFR, PDGFR is also presented in this book.Given its breath, this book will appeal to medicinal chemists, students, researchers and professionals alike.Table of ContentsProteinKinase-Inhibitors: A Story of Success.- Function, Structure and Topology of Proteinkinases.- Molecular Modelling.- Case study on Receptor Tyrosine Kinases EGFR, VEGFR, PDGFR.- Achieving high level of selectivity for kinase inhibitors.- Inhibitors of c-Jun N-terminal kinase 3.- Exploiting kinase inhibitors for cancer treatment - An Overview of Clinical Results and Outlook.- Covalent Janus Kinase 3 Inhibitors.
£104.49
Springer International Publishing AG Principles and Practices of Lyophilization in
Book SynopsisThe biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T cell engager ( BITES), Dual Variable Domain ( DVD), Chimeric Antigen Receptor - Modified Tcells (CART) that are currently being used as therapeutic agents for immunology and oncology disease conditions. In addition to other pharmaceuticals and biopharmaceuticals, all these novel formats are fragile with respect to their stability/structure under processing conditions meaning marginal stability in the liquid state and often require lyophilization to enhance their stability and shelf-life. This book contains chapters/topics that will describe every aspect of the lyophilization process and product development and manufacturing starting from the overview of lyophilization process, equipment required, characterization of the material, design and development of the formulation and lyophilization process, various techniques for characterization of the product, scale-up/tech-transfer and validation. It also describes the application of CFD coupled with mathematical modeling in the lyophilization process and product development, scale-up, and manufacturing. Additionally, Principles and Practice of Lyophilization Process and Product Development contains an entire dedicated section on “Preservation of Biologicals” comprised of nine chapters written by experts and including case studies.Table of Contents1. Overview of Freeze Drying2. Characterization and Determination of Freeze Drying Properties of Frozen Formulations- Case Studies3. Beyond pH: Acid/base relationships in frozen and freeze-dried pharmaceuticals4. Concepts and Strategies in the Design of Formulation for Freeze Drying5. Formulation Design for Freeze Drying - Case studies of Stabilization of Proteins6. Challenges and Considerations in the Development of a High Protein Concentration Lyophilized Drug Product7. Freeze-drying of thermosensible pharmaceuticals with organic co-solvent + water formulations8. Primary container closure system selection for lyophilized drug products9. Vial Breakage During Lyophilization10. The Nucleation of Ice11. Stresses, Stabilization, and Recent Insights in Freezing of Biologics12. Lyophilization Process Understanding and Scale-up using ab initio Vial Heat Transfer Modeling13. Secondary drying: Challenges and Considerations14. Design and Process Considerations in Spray Freeze Drying15. LyoPRONTO: Deterministic and Probabilistic Modeling. Tutorial and Case Study16. Utilizing Solid-State NMR Spectroscopy to Assess Properties of Lyophilized Formulations17. Design of Moisture Studies for a Lyophilized Product18. Laser-Based Headspace Moisture Analysis for Rapid Nondestructive Moisture Determination of Lyophilized Products19. Application of PAT in Real-time Monitoring and Controlling of Lyophilization Process20. Process Analytical Technology (PAT) for Lyophilization Process Monitoring and End Point Detection21. Advances in Process Analytical Technology – A Small Scale Freeze-Dryer for Process Analysis, Optimization, and Transfer Advances in Process Analytical Technology – A Small Scale Freeze-Dryer for Process Analysis, Optimization, and Transfer22. Overview of Heat and Mass Transfer Modeling in Lyophilization to Create Design Spaces and Improve Process Analytical Tool (PAT) Capability23. Application of QbD elements in the Development and Manufacturing of a Lyophilized product.- Characterization of Freeze Dryer24. Characterization of Freeze Dryer25. Scale-up and Technology Transfer of a Lyophilization Process26. Lyophilization Validation: Process Design and Modeling27. Lyophilization Validation: Process Qualification and Continued Process Verification28. Homogeneity Assessment of Lyohilized Biological Drug Products During Process Performance Qualification29. Informed Manufacturing through the use of Big Data Analytics for Freeze Drying Process & Equipment30. Multivariate Analysis for Process Understanding, Continuous Process Verification and Condition Monitoring of Lyophilization Processes31. Lyophilized Drug Product Cake Appearance: What Is Acceptable?
£125.99
Springer International Publishing AG Pharmaceutical Biotechnology: Fundamentals and
Book SynopsisThis introductory text explains both the basic science, production, quality, dosage forms, administration, economic and regulatory aspects and the clinical applications of biotechnology-derived pharmaceuticals. It serves as a complete one-stop source for undergraduate/graduate pharmacists and pharmaceutical science students. An additional important audience are pharmaceutical scientists in industry and academia, particularly those who have not received formal training in pharmaceutical biotechnology and are inexperienced in this field. The rapid growth and advances in the field made it necessary to revise this textbook in order to continue providing up-to-date information and introduce readers to cutting edge knowledge and technology of this field. This Sixth Edition completely updates the previous edition and includes additional coverage on new approaches such as oligonucleotides, siRNA, mRNA, gene therapy, cell therapies, monoclonal antibodies and vaccines. With more than 3-million-chapter downloads, the fifth edition of the textbook has achieved widespread distribution as a key educational resource for the field of pharmaceutical biotechnology. Table of ContentsMolecular Biotechnology.- Biophysical and biochemical analysis of recombinant proteins.- Production and downstream processing of biotech products.- Formulation of biotech products, including biopharmaceutical considerations.- Pharmacokinetics and pharmacodynamics of peptide and protein drugs.- Immunogenicity of pharmaceutical proteins.- General considerations of monoclonal antibodies from structure to therapeutic application.- Genomics, Other “Omics” Technologies, Personalized Medicine and Additional Biotechnology-Related Techniques.- Dispensing biotechnology products: handling, professional education and product information.- Economic considerations in medical biotechnology.- Regulatory framework for biosimilars.- Vaccines.- Oligonucleotides and siRNA.- Gene therapy.- Stem cell technology.- Therapeutic Applications.-Endocrinology.- Insulin.- Follicle-stimulating hormone.- Growth hormone.- Cardiovascular and Respiratory Applications.- Recombinant coagulation factors and thrombolytics.- Recombinant human deoxyribonuclease.- Oncology.- Monoclonal antibodies in oncology .- Hematopoetic growth factors.- Inflammation and Immunemodulation.- Monoclonal antibodies in transplantation.- Monoclonal antibodies and antibody-based therapeutics in anti-inflammatory therapy.- Interferons and interleukins.- Anti-infectious diseases.- Monoclonal antibodies.- Enzyme replacement therapy.
£67.49
De Gruyter Active Pharmaceutical Ingredient Manufacturing: Nondestructive Creation
Book SynopsisThe book reviews the history of current brand and generic business in pharmaceuticals manufacturing practices. Based on examples, the reader can interpolate, extrapolate and exploit mutual behavior (physical and chemical properties) of chemicals to design and commercialize processes that fulfi ll the demands, also manipulate chemical unit processes and unit operations to reduce/minimize effl uents and lower environmental impact i.e. reduce global warming. Readers will be able to simplify process development, design and commercialize economic manufacturing processes.
£75.05
De Gruyter Product-Driven Process Design: From Molecule to Enterprise
Book SynopsisProduct-driven process design – from molecule to enterprise provides process engineers and process engineering students with access to a modern and stimulating methodology to process and product design. Throughout the book the links between product design and process design become evident while the reader is guided step-by-step through the different stages of the intertwining product and process design activities. Both molecular and enterprise-wide considerations in design are introduced and addressed in detail. Several examples and case studies in emerging areas such as bio- and food-systems, pharmaceuticals and energy are discussed and presented. This book is an excellent guide and companion for undergraduate, graduate students as well as professional practitioners.
£72.68
de Gruyter Pharmaceutical Chemistry
Book Synopsis
£54.75
De Gruyter Industrial Pharmaceutical Chemistry: Product Quality
Book SynopsisThis book discusses the effects of prolonged hypoventilation, or a pulmonary condition on hypoxia, and hypercapnia, its effect on the formation of some joint diseases, and the types of natural medicine used in the treatment of each joint disease. You will also find methods used to calculate thermodynamic parameters. You can also learn optimized structures for these chemical compounds. The book includes a listing of the thermodynamic table for literature values for standard enthalpy of formation, and C-H and O-H Bond dissociation energizes energies for some chemical compounds; simple multi-fluorinated organic alcohols.
£60.80
de Gruyter Chemistry of Nucleic Acids
Book Synopsis
£73.80
de Gruyter Organic Chemistry 25 MustKnow Classes of Organic
Book Synopsis
£56.52
De Gruyter Carbohydrates in Chemistry and Biology
Book Synopsis
£131.85
Walter de Gruyter Mein Mikrobiom Meine Gene Und Ich
Book Synopsis
£35.96
Wiley-VCH Verlag GmbH Computational Drug Discovery, 2 Volumes: Methods
Book SynopsisComputational Drug Discovery A comprehensive resource that explains a wide array of computational technologies and methods driving innovation in drug discovery Computational Drug Discovery: Methods and Applications (2 volume set) covers a wide range of cutting-edge computational technologies and computational chemistry methods that are transforming drug discovery. The book delves into recent advances, particularly focusing on artificial intelligence (AI) and its application for protein structure prediction, AI-enabled virtual screening, and generative modeling for compound design. Additionally, it covers key technological advancements in computing such as quantum and cloud computing that are driving innovations in drug discovery. Furthermore, dedicated chapters that addresses the recent trends in the field of computer aided drug design, including ultra-large-scale virtual screening for hit identification, computational strategies for designing new therapeutic modalities like PROTACs and covalent inhibitors that target residues beyond cysteine are also presented. To offer the most up-to-date information on computational methods utilized in Computational Drug Discovery, it covers chapters highlighting the use of molecular dynamics and other related methods, application of QM and QM/MM methods in computational drug design, and techniques for navigating and visualizing the chemical space, as well as leveraging big data to drive drug discovery efforts. The book is thoughtfully organized into eight thematic sections, each focusing on a specific computational method or technology applied to drug discovery. Authored by renowned experts from academia, pharmaceutical industry, and major drug discovery software providers, it offers an overview of the latest advances in computational drug discovery. Key topics covered in the book include: Application of molecular dynamics simulations and related approaches in drug discovery The application of QM, hybrid approaches such as QM/MM, and fragment molecular orbital framework for understanding protein-ligand interactions Adoption of artificial intelligence in pre-clinical drug discovery, encompassing protein structure prediction, generative modeling for de novo design, and virtual screening. Techniques for navigating and visualizing the chemical space, along with harnessing big data to drive drug discovery efforts. Methods for performing ultra-large-scale virtual screening for hit identification. Computational strategies for designing new therapeutic models, including PROTACs and molecular glues. In silico ADMET approaches for predicting a variety of pharmacokinetic and physicochemical endpoints. The role of computing technologies like quantum computing and cloud computing in accelerating drug discovery This book will provide readers an overview of the latest advancements in Computational Drug Discovery and serve as a valuable resource for professionals engaged in drug discovery.Table of ContentsVolume 1 Preface xv Acknowledgments xix About the Editors xxi Part I Molecular Dynamics and Related Methods in Drug Discovery 1 1 Binding Free Energy Calculations in Drug Discovery 3Anitade Ruiter and Chris Oostenbrink 2 Gaussian Accelerated Molecular Dynamics in Drug Discovery 21Hung N. Do, Jinan Wang, Keya Joshi, Kushal Koirala, and Yinglong Miao 3 MD Simulations for Drug-Target(Un)binding Kinetics 45Steffen Wolf 4 Solvation Thermodynamics and its Applications in Drug Discovery 65Kuzhanthaivelan Saravanan and Ramesh K. Sistla 5 Site-Identification by Ligand Competitive Saturation as a Paradigm of Co-solvent MD Methods 83Asuka A. Orr and Alexander D. MacKerell Jr. Part II Quantum Mechanics Application for Drug Discovery 119 6 QM/MM for Structure-Based Drug Design: Techniques and Applications 121Marc W. van der Kamp and Jaida Begum 7 Recent Advances in Practical Quantum Mechanics and Mixed-QM/MM-Driven X-Ray Crystallography and Cryogenic Electron Microscopy (Cryo-EM) and Their Impact on Structure-Based Drug Discovery 157Oleg Borbulevych and Lance M. Westerhoff 8 Quantum-Chemical Analyses of Interactions for Biochemical Applications 183Dmitri G. Fedorov Part III Artificial Intelligence in Pre-clinical Drug Discovery 211 9 The Role of Computer-Aided Drug Design in Drug Discovery 213Stormvander Voort, Andreas Bender, and Bart A. Westerman 10 AI-Based Protein Structure Predictions and Their Implications in Drug Discovery 227Tahsin F. Kellici, Dimitar Hristozov, and Inaki Morao 11 Deep Learning for the Structure-Based Binding Free Energy Prediction of Small Molecule Ligands 255Venkatesh Mysore, Nilkanth Patel, and Adegoke Ojewole 12 Using Artificial Intelligence for de novo Drug Design and Retrosynthesis 275Rohit Arora, Nicolas Brosse, Clarisse Descamps, Nicolas Devaux, Nicolas Do Huu, Philippe Gendreau, Yann Gaston-Mathé, Maud Parrot, Quentin Perron, and Hamza Tajmouati 13 Reliability and Applicability Assessment for Machine Learning Models 299Fabio Urbina and Sean Ekins Volume 2 Preface xv Acknowledgments xix About the Editors xxi Part IV Chemical Space and Knowledge-Based Drug Discovery 315 14 Enumerable Libraries and Accessible Chemical Space in Drug Discovery 317Tim Knehans, Nicholas A. Boyles, and Pieter H. Bos 15 Navigating Chemical Space 337Akos Tarcsay, András Volford, Jonathan Buttrick, Jan-Constantin Christopherson, Máte Erdos, and Zoltán B. Szabó 16 Visualization, Exploration, and Screening of Chemical Space in Drug Discovery 365José J. Naveja, Fernanda I. Saldívar-González, Diana L. Prado-Romero, Angel J.Ruiz-Moreno, Marco Velasco-Velázquez, Ramón Alain Miranda-Quintana, and José L. Medina-Franco 17 SAR Knowledge Bases for Driving Drug Discovery 395Nishanth Kandepedu, Anil Kumar Manchala, and Norman Azoulay 18 Cambridge Structural Database (CSD)–Drug Discovery Through Data Mining & Knowledge-Based Tools 419Francesca Stanzione, Rupesh Chikhale, and Laura Friggeri Part V Structure-Based Virtual Screening Using Docking 441 19 Structure-Based Ultra-Large Virtual Screenings 443Christoph Gorgulla 20 Community Benchmarking Exercises for Docking and Scoring 471Bharti Devi, Anurag TK Baidya, and Rajnish Kumar PartVI In Silico ADMET Modeling 495 21 Advances in the Application of In Silico ADMET Models–An Industry Perspective 497Wenyi Wang, Fjodor Melnikov, Joe Napoli, and Prashant Desai Part VII Computational Approaches for New Therapeutic Modalities 537 22 Modeling the Structures of Ternary Complexes Mediated by Molecular Glues 539Michael L. Drummond 23 Free Energy Calculations in Covalent Drug Design 561Levente M. Mihalovits, György G. Ferenczy, and György M. Keseru Part VIII Computing Technologies Driving Drug Discovery 579 24 Orion A Cloud-Native Molecular Design Platform 581Jesper Sorensen, Caitlin C. Bannan, Gaetano Calabrò, Varsha Jain, Grigory Ovanesyan, Addison Smith, She Zhang, Christopher I. Bayly, Tom A. Darden, Matthew T. Geballe, David N. LeBard, Mark McGann, Joseph B. Moon, Hari S. Muddana, Andrew Shewmaker, Jharrod LaFon, Robert W. Tolbert, A. Geoffrey Skillman, and Anthony Nicholls 25 Cloud-Native Rendering Platform and GPUs Aid Drug Discovery 617Mark Ross, Michael Drummond, Lance Westerhoff, Xavier Barbeu, Essam Metwally, Sasha Banks-Louie, Kevin Jorissen, Anup Ojah, and Ruzhu Chen 26 The Quantum Computing Paradigm 627Thomas Ehmer, Gopal Karemore, and Hans Melo Index 679
£172.44
Harwood-Academic Publishers Growth and Hyperplasia of Cardiac Muscle Cells
Book SynopsisFirst Published in 1991. This Volume three of a set of a monograph series publishing versions of some of the research reviewed in its companion series, Section A (Cardiology Reviews) of Soviet Medical Reviews.Table of ContentsPreface PART I NORMAL GROWTH OF DEVELOPING CARDIAC MUSCLE Chapter 1 Differentiation of Cardiomyocytes Chapter 2 Reproduction of Cardiac Myocytes Developing In Vivo and its Relation to Processes of Differentiation PART 11 CELLULAR ASPECTS OF REGENERATIVE PROCESSES AND HYPERPLASIA IN THE INJURED AND OVERLOADED MYOCARDIUM Chapter 3 Regenerative Processes in the Myocardium of Cold-B1ooded Animals Chapter 4 Proliferation of Cardiac Myocytes in the Injured and Overloaded Myocardium du ring Early Ontogenesis of Warm-Blooded Animals and Man Reactive hyperplasia of cardiomyoeytes of the injured heart of embryos and neonatal animals Chapter 5 Regenerative Possibilities of the Ventricular Myocardium of Adult Mammals Chapter 6 Unusual Proliferative Behavior of Adult Mammalian Atrial Cardiomyocytes Chapter 7 On the Possibility of Reactivation of Proliferative Processes in Cardiomyocytes Of the Conducting System Chapter 8 A Paradoxical Capacity of Working Myocytes of the Overloaded Heart of Man and Primates for Polyploidization Chapter 9 Attempts to Stimulate Myocardial Regeneration PART III MODULATION OF PROCESSES OF CARDIOMYOCYTE DIFFERENTlATION AND PROLIFERATION IN VITRO AND IN TISSUE TRANSPLANTS Chapter 10 Modulations of Differentiation in Tissue Explants of the Myocardium In Vitra Chapter II Processes of Cardiomyocyte Proliferation and Differentiation in Cell Culture Chapter 12 Regenerative Morphogenesis du ring Auto- and Heterotransplantation of Myocardial Tissue Grafts
£308.75
CRC Press The Pharmaceutical Index: 2013 Worldwide NCEs
Book SynopsisAn ideal drug candidate should possess good pharmacological activity, absorption, distribution, metabolism, excretion and toxicity properties. Historically, there are around 6,000 drugs being used in humans and approximately 3,000 still in clinical use, not including herbal medicines. This Pharmaceutical Index series focuses on the profiles of 500 pharmaceutically marketed products from the past two decades. Professor Dr. K. Barry Sharpless is Honorary Editor-in-Chief of this first Index by Pharmacodia. The volume includes 24 NCEs worldwide approved drugs in 2013. Pharmacodia plan to publish two further volumes which will feature 2014 NCEs (32 drugs) and 2015 NCEs (25 drugs).
£380.00
CBS Publishers & Distributors Practical Pharmaceutical Chemistry
Book Synopsis
£13.12
River Publishers Pharmaceutical industry 4.0: Future, Challenges &
Book SynopsisThe pharmaceutical industry is on the cusp of a new age, with the need for personalized therapy, more complex production processes, smaller batch sizes and rising manufacturing costs. It is necessary to continuously adapt to the rapidly changing environment using novel technology and improved operational efficiency and flexibility. To achieve this, intelligent manufacturing seems to be a definite answer. Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. This book provides a deep insight into key technologies that will modernize pharmaceutical manufacturing and facilitate digital transformation. Throughout the book we discuss technologies, application and challenges for applying digital technology in pharmaceutical industry, including: • Focus on an overview of Industry 4.0 and its application in the pharmaceutical field• Most recent advances in the pharmaceutical industry• Understanding the concepts of emerging technology trends for drug discovery.Table of Contents1. Digitalization in the Pharmaceutical Industry: Prioritization Throughout Digital Transformation 2. Applications of Industry 4.0 to the Pharmaceutical Sector 3. Blockchain in Pharmaceutical Industry: Opportunities and Challenges 4.Patient Monitoring using Blockchain 5. Potential of AI in Advancement of the Pharmaceutical Industry 6. Use of Artificial Intelligence and Robotics: Making the Drug Development Process Easier 7. Pharmaceutical Packaging: New Impulse Through Artificial Intelligence 8. Digital Assistant in Healthcare Systems: Application and Challenges 9. Deep Learning Techniques and Drug Release 10. Tissue Response Study Using Deep Learning Techniques 11. Issues and Challenges in Bioinformatics Tools for Clinical Trials 12. Advancement in Artificial Intelligence: Insights and Future Vision for Pharmacy Profession
£104.50
Taylor & Francis Ltd Submicron Emulsions in Drug Targeting and
Book SynopsisIt is anticipated that submicron emulsion and lipid suspension will find numerous and novel medical applications in the near future. The purpose of this multi-authore book is to provide the reader with an up-to-date general overview of submicron emulsions and lipid suspensions (solid lipid nanoparticles) as well as to emphasize the various methods of preparation, characerization, evaluation and potential applications in various therapeutic areas.Leading authors have contributed to this unique book which contains all state of the art and detailed knowledge related to the physico-chemical, pharmaceutical and medical aspects of these most interesting but complex dosage forms, thus making this information easily available to the reader. This book will be of interest to scientists working in the field of drug delivery and targeting in universities as well as in the pharmaceutical, food, cosmetic, veterinary and chemical industries.Table of Contents1. Introduction and Overview Part 1. Intravenous Fat Emulsions 2. Perspectives on the Use of Intravenous Lipid Emulsions in Man 3. Particle-Sizing Technologies for Submicron Emulsions 4. Biofate of Fat Emulsions Part 2. Submicron Emulsions as Therapeutic Delivery Systems 5. Design and Evaluation of Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration 6. Submicron Emulsions as Drug Carriers for Tropical Administration 7. Emulsions of Supercooled Melts - A Novel Drug Delivery System 8. Submicron Lipid Suspensions (Solid Lipid Nanoparticles) Versus Lipid Nanoemulsions: Similarities and Differences 9. Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery Part 3. Perfluorochemical Submicron Emulsions 10. The Design and Engineering of Oxygen-Delivering Fluorocarbon Emulsions
£199.50
Swedish Pharmaceutical Press Drugs of Natural Origin: A Treatise of
Book SynopsisDrugs of Natural Origin is a unique multidisciplinary book suitable for undergraduate and graduate students and teachers in the area of natural product science, but also as a complementary book for disciplines like medicinal chemistry, biochemistry and pharmacology. The book can also serve society as a scientific source for the understanding of a sustainable use of natural products in the development of new drugs, scientifically based herbal remedies, and environmentally friendly biomolecules.During evolution, molecules have been developed for specific functions in nature. These bioactive substances have a potential as new drug candidates in drug development, but also as pharmacological tools, intermediates or templates for synthesis of drugs. This book deals with terrestrial and marine bioactive substances of plant, microbial or animal origin. The occurrence, biosynthesis, isolation, chemistry and medical use are described together with basic research strategies. An increased understanding of the medical importance of bioactive natural products has developed in society. Since the publication of the sixth edition, six years ago, considerable progress has been achieved in the study of biosynthetic pathways, mainly based on gene technology. The revolution in high-throughput sequencing technology has given an increasing access to microbial genome sequences, which opens up new possibilities in the discovery of novel bioactive natural products. This development is reflected in a substantial revision and expansion of the book, but also removal of some sections containing products remotely associated with drugs. The new book also contains description of novel drugs marketed since the publication of the previous edition, especially in the field of diabetes, cancer and infection.
£171.00
IAEA Guidance for Preclinical Studies with
Book SynopsisPreclinical or nonclinical evaluation is an integral part of the development of any drug. The process of developing a new radiopharmaceutical includes rigorous testing before it can be cleared for use in humans. There must be in-depth characterization of its behaviour to assess its safety and suitability for the intended clinical application. This publication provides a baseline guide for preclinical evaluation of radiopharmaceuticals that will give its readers a general review of the requirements of a facility and insight into the various scientific activities that constitute this process. The principles and protocols discussed herein will provide guidelines for biological assessment of candidate compounds, which are consistent with the principles of good laboratory practices to generate valid nonclinical scientific data towards approval for clinical translation. This publication is intended not only for researchers engaged in radiopharmaceutical development, but also for the Member States planning to set up or upgrade facilities for radiopharmaceuticals' research.
£38.90
World Scientific Publishing Co Pte Ltd Therapeutic Protein Targets For Drug Discovery
Book SynopsisThe book reviews the recent research advances and their outcomes in the areas of structural biology, bioinformatics, phytochemistry and drug discovery. Chapters in the book cover multidisciplinary research to understand the molecular mechanisms involved in protein-protein/ligand interactions. It employs an integrative approach to identify the therapeutic targets for HIV, and cancer, pathogen and viral infection pathways and the identification of their potential drug candidates. The book also provides examples of computational molecular dynamics simulations to understand the conformational changes in the molecules. Some chapters are focused on exploring potent bioactive compounds from natural sources.This book can serve as a single source that covers several interdisciplinary research fields which will be beneficial to Researchers and students in postgraduate studies.
£121.50
Springer Verlag, Singapore A Practical Guide to Pharmacological
Book SynopsisPharmacological biotechnology is applied to and used to study drug development, working mechanisms, diagnosis, and therapies. This textbook covers the whole range of experiments related to pharmacology. It also contains basic laboratory safety guidelines along with the basic calculations and formulas used in a laboratory. Each chapter starts with an introduction/theory into the basic approach followed by detailed methods sections with easy-to-follow protocols and comprehensive troubleshooting, calculations and possible questions for examination. The target group is researchers who are studying pharmacological biotechnology in the laboratory.Table of ContentsPart1.Introduction.- 1.1 Rules of laboratory safety in a pharmacology laboratory.- 1.2 Commom instruments and their uses used in a pharmacology laboratory.- Part2.General aspects of Pharmacology laboratory.- 2.1 Safety and Risk assessment.- 2.2 Use and Handling of laboratory animals.- 2.3 Experimental design.- 2.4 Essential statistics.- 2.5 Cumulative Dose Response Curve.- 2.6 Toxicology.- 2.7 Basic instruments and techniques in Pharmacology Laboratory .- Part3.Isolated tissues and organs.- 3.1 Basic instruments used for isolated tissue experiments.- 3.2 Organ baths.- 3.3 Smooth muscle preparations.- 3.4 Skeletal muscle preparations.- 3.5 Cardiac muscle preparations.- Part4.Isolated tissues for screening of drugs.- 4.1 Evaluation of antidiabetic agents.- 4.2 Evaluation of antidepressants.- 4.3 Evaluation of antihypertensive agents.- 4.4 Evaluation of antiulcer agents.- 4.5 Evaluation of hepatotoxicity.- 4.6 Evaluation of Antioxidant agents.- 4.7 Evaluation of local anaesthetics.- Part5.Genotoxicity and Toxicological studies.- 5.1 The Mouse Lymphoma Assay.- 5.2 The Comet Assay.- 5.3 In vitro Genotoxicity assay.- 5.4 In vitro Teratogenicity Testing.- 5.5 Histopathological studies of animal tissues.- 5.6 Drug poisoning.- Part6.Experimental Animal studies.- 6.1 Pyrogen testing.- 6.2 Collecting blood from mice.- 6.3 Studies on different parameters of blood.- 6.4 Experiment on central nervous system.- 6.5 Evaluation on cardiovascular system.- 6.6 Experiments on GI tract.- Part7.Clinical trials.- 7.1 Clinical Pharmacology and its genesis.- 7.2 National and International agencies and their role in Clinical pharmacology.- 7.3 Stages in drug development and clinical trials.- 7.4 Ethics in Clinical research.- 7.5 Safety assessment in Clinical trials.- Part8.IPR and ethics in animal studies.- 8.1 Intellectual property rights and its different categories.- 8.2 Importance of IPR in drug development.- 8.3 Patenting cells, cell lines and animals.- 8.4 Ethics in laboratory animal studies .- 8.5 Risk assessment and management.- 8.6 Good laboratory practices.
£52.49
Springer Verlag, Singapore Middle Molecular Strategy: Flow Synthesis to
Book SynopsisThis book highlights recently discovered aspects of “middle-size molecules,” focusing on (1) their unique bio-functions on the basis of derivatives and conjugates of natural products, saccharides, peptides, and nucleotides; (2) the synthesis of structurally complex natural products; (3) special synthetic methods for π-conjugated functional molecules; and (4) novel synthetic methods using flow chemistry. Given its scope, the book is of interest to industrial researchers and graduate students in the fields of organic chemistry, medicinal chemistry, and materials science. Table of ContentsPart I: Development of bio-functional middle molecules.- 1. Introduction.- 2. Total Synthesis, Biological Evaluation and 3D Structural Analysis of Cyclodepsipeptide Natural Products.- 3. Development of the Middle-size Molecules for Alkylation to Higher-Order Structures of Nucleic Acids.- 4. In Situ Synthesis of Glycoconjugates on Cell Surface: Selective Cell Imaging Using Low-Affinity Glycan Ligands.- 5. Assembled mid-sized agents that control intracellular protein-protein interactions.- 6. Macrocyclic mid-sized peptides with new chemical modalities.- Part II: Achievement of highly efficient synthesis of bioactive middle molecules.- 7. Enantioselective Total Synthesis of Cotylenin.- 8. Flow Chemistry for the Construction of Polycyclic Skeleton.- 9. Electrochemical Synthesis of Oligosaccharides as Middle-sized Molecules.- 10. Efficient Synthesis of Biologically Active Peptides based on Micro-flow Amide Bond Formation.- 11. Design and Concise De Novo Synthesis of Artemisinin Analogs.
£125.99
Pan Stanford Publishing Pte Ltd Dendrimer-Based Nanomedicine
Book SynopsisIn recent decades, dendrimers — free-shaped synthetic macromolecules — have garnered a great deal of scientific interest because of their unique molecular nanostructure. Used in a variety of scientific applications, dendrimers are now widely regarded as a safer, more precise and more effective way to practice medicine.This book compiles and details cutting-edge research in science and medicine from the interdisciplinary team of the Michigan Nanotechnology Institute for Medicine and Biological Sciences, which is currently revolutionizing drug delivery techniques through the development of engineered nanodevices. Edited by Istvan J. Majoros and James R. Baker Jr, two prominent nanotechnology researchers, this book will appeal to anyone involved in nanotechnology, macromolecular science, cancer therapy or drug delivery research. Trade Review"The authors' approach to fill in a little history with futuristic perspective will be a delight to all readers interested in the field. A must read."—Prof. George R. Newkome, The University of Akron, USATable of ContentsTargeted Drug Delivery in General, New Technology in Medicine. General Carriers for Drug Delivery. Poly(amidoamine) Dendrimer Synthesis and Characterization. Optical and Biophotonic Applications of Dendrimer Conjugate. Dendrimer Conjugates for Cancer Treatment. Biological Application of PAMAM Dendrimer Nanodevices in vitro and in vivo. Dendrimer-based Targeted Apoptosis Sensors for Medical Application. MRI Using Targeted Dendrimer Contrast Agents. Nanoparticle — Membrane Interactions: Mechanism for Enhanced Permeability. Computer Simulations of Dendrimers. Dendrimer-Entrapped and Dendrimer-Stabilized Metal Nanoparticles for Biomedical Applications.
£153.00
Pan Stanford Publishing Pte Ltd Bio-Inspired Regenerative Medicine: Materials,
Book SynopsisThis book presents a wide and interdisciplinary overview of the current state of the art in the development of biomimetic materials for tissue regeneration on the basis of relevant and high-impact clinical needs. It specifically emphasizes the regeneration of bone, cartilage, and osteochondral tissues as well as soft tissues such as nerves, heart, and endocrine organs. It brings together contributions from materials scientists, biologists, and surgeons with globally recognized experience in the field of regenerative medicine.The aim of the book is to highlight the relevance of biomimetics as an elective approach for the development of new scaffolds that can direct regenerative cascade by means of chemico-physical and topological nano-cues presented to cells and biologic tissues. Particularly, the book refers to emerging concepts in synthesis processes and scaffolds inspired by nature as well as to novel approaches for smart functionalization such as the use of magnetic signaling.Trade Review"This well-written book is essential reading for professionals and students from materials science, materials engineering, biology, or medicine who wish to know the state of the art on biomimetic-inspired materials for surgical applications. All fields are clearly presented, from powder synthesis to scaffold processing, tissue engineering, interaction between biomaterials and living cells, and biomechanical behavior. It is a good reference point for the foreseeable future."—Prof. Anne Leriche, University of Valenciennes, FranceTable of ContentsBio-Inspired Nanomaterials and Nano-Bio-Magnetism in Regenerative Medicine. Nano-Apatites. Biomorphic Scaffolds. Nanocomposites for Bone and Osteochondral Regeneration. Nerve Regeneration. Heart Regeneration. Triggering Cell-Biomaterial Interaction. Clinical Perspective of Bone Regeneration in Orthopaedics and Spine Surgery. Clinical Aspects Related to Osteochondral Regeneration. Organomorphic Approach to Bio-Artificial Endocrine Organs.
£99.00
Pan Stanford Publishing Pte Ltd Drug Delivery Across Physiological Barriers
Book SynopsisTransport of pharmaceutical agents in the body is paramount to therapeutic efficacy. Advances in the past decades have rendered a remarkable improvement of drug delivery strategies, which has helped to increase the bioavailability of therapeutic agents by protecting them from degradation, targeting them to diseased sites, and controlling their circulation time and release rate. Additionally, for most therapeutics, reaching the targets of action require penetration across tissues and/or entry within cells. The design of strategies to control the transport of therapeutic compounds through these physiological barriers has become an imperative and a challenging need in the quest for better therapeutics. This book provides an overview of the current advances in this field, including considerations on the biological regulation and natural mechanisms overcoming these barriers, as well as drug delivery strategies facilitating the transport of drugs and their carriers at the tissue, cell, and subcellular levels. Trade Review"This book combines a thorough overview of the barriers encountered and strategies employed to increase the delivery of therapeutics. It also provides a critical assessment of the merits and limitations of delivery approaches. Overall, this is a concentrate of the most recent scientific discoveries written by highly recognized authors in the field. It is an excellent reference for both students and seasoned scientists."—Dr. Mohamed ElSayed, University of Michigan, USA"Drug delivery across physiological barriers is a historic and challenging problem. This compelling book addresses this topic thoroughly, with detailed chapters ranging from descriptions of the composition of physiological barriers, through barrier-penetrating drug delivery strategies to how drugs are trafficked once inside cells. A must-have addition to any pharmaceutical scientist’s technical library." —Dr. John D. Higgins, Merck & Co., USA"Drug Delivery Across Physiological Barriers is a fundamental book in nanomedicine, particularly for those who start in the field of designing therapeutic strategies based on nano-drug delivery systems. It addresses the challenging anatomical and pathological barriers of the epithelia, endothelia, extracellular matrix, and cell endocytic pathways. It shows that a thorough understanding of the stepwise processing to which nanostructures are exposed throughout the body and intracellularly is a critical tool for a wise design of nanomedicines." —Dr. Eder L. Romero, National University of Quilmes, ArgentinaTable of ContentsIntroduction. Physiological Barriers Controlling Penetration and Transport of Substances in the Body. Structure and function of epithelial and endothelial barriers. The plasma membrane as a semipermeable barrier. Biology and regulation of protein sorting and vesicular transport. Pathogens and intracellular transport. Strategies for Drug Penetration across Tissue Compartments. Drug transport across the skin. Mucosal barriers. Transport of therapeutics across the gastrointestinal epithelium. Crossing the endothelial barrier. Nanoparticle-based drug delivery to solid tumors. Drug Transport into Cells and Subsequent Intracellular Trafficking. Membrane lipids and drug transport. Drug delivery systems that fuse with the plasmalemma. Endocytosis and the endolysosomal route in drug delivery. Endo-lysosomal escape. Intracellular transport to the mitochondria and other organelles.
£99.00
Pan Stanford Publishing Pte Ltd Tuning Innovation with Biotechnology
Book SynopsisThis book deals with evolving intelligence systems and their use in immune algorithm (IM), particle swarm optimization (PSO), bacterial foraging (BF), and hybrid intelligent system to improve plants, robots, etc. It discusses the motivation behind research on and background of evolving intelligence systems and illustrates IM-based approach for parameter estimation required for designing an intelligent system. It approaches optimal intelligent tuning using a hybrid genetic algorithm–particle swarm optimization (GA-PSO) and illustrates hybrid GA-PSO for intelligent tuning of vector system. Table of ContentsBackground. Immune Network–Based Parameter Estimation. Intelligent PID Controller Tuning Using a Hybrid GA-PSO Approach. GA-PSO-Based PI Controller Tuning for Indirect Vector Control of Three-Phase Induction Motor. Novel Hybrid System Based on GA and Bacteria Foraging. Conclusion.
£85.50
Pan Stanford Publishing Pte Ltd Embedding New Technologies into Society: A
Book SynopsisThe embedding of any new technologies in society is challenging. The evolving state of the scientific art, often-unquantifiable risks and ill-defined developmental trajectories have the potential to hinder innovation and/or the commercial success of a technology. The are, however, a number of tools that can now be utilized by stakeholders to bridge the chasm that exists between the science and innovation dimensions on the one hand, and the societal dimensions on the other. This edited volume will draw together leading researchers from the domains of law, philosophy, political science, public administration and the natural sciences in order to demonstrate how tools such as, for example, constructive technology assessment, regulatory governance and societal scenarios, may be employed by stakeholders to assist in successfully embedding new technologies into society. This volume will focus primarily on the embedding of two emergent and emerging technologies: nanotechnologies and synthetic biology. Government, industry and the epistemic community continue to struggle with how best to balance the promised benefits of an emerging technology with concerns about its potential impacts. There is a growing body of literature that has examined these challenges from various cultural, scientific and jurisdictional dimensions. There is, however, much work that still needs to be done; this includes articulating the successes and failures of attempts to the societal embedding of technologies and their associated products. This edited volume is significant and timely, as unlike other books currently on the market, it shall draw from real work experiences and experiments designed anticipate the societal embedding of emerging technologies. This empirical work shall be supported by robust theoretical underpinnings.Table of ContentsIntroduction - Foxes become hedgehogs. Reflexive co-evolution and governance patterns. Governance approaches for emerging technologies. Society as a laboratory to experiment with new technologies. Care and technoscience: re-embedding the future of innovation. Division of moral labour as an element in the governance of emerging technologies. Ethical reflexivity as capacity building: supportive tools and approaches. The demand side of innovation governance: Demand articulation processes in the case of nano-based sensor technologies. Evolving Patterns of Governance of and by Expectations. The Graphene Hype Wave. Transnational challenges of governing new technologies: The case of nanotechnology. Co-Regulation of Nanomaterials: On Collaborative Business Association Activities directed at Contributing to Occupational Health and Safety. The ‘Metamorphosis’ of the drone: the governance challenges of drone technology in border surveillance. On the disruptive potential of 3D printing. Modifying Materials, Mosquitoes and Measures: The Regulation of Nanotechnologies and Synthetic Biology. Conclusions.
£60.79
Pan Stanford Publishing Pte Ltd Capillary Electrophoresis: Trends and
Book SynopsisCapillary electrophoresis (CE) has become an established method with widespread recognition as an analytical technique of choice in numerous analytical laboratories, including industrial and academic sectors. Pharmaceutical and biochemical research and quality control are the most important CE applications. This book provides a comparative assessment of related techniques on mode selection, method development, detection, and quantitative analysis and estimation of pharmacokinetic parameters and broadens the understanding of modern CE applications, developments, and prospects. It introduces the fundamentals of CE and clearly outlines the procedures used to mitigate several barriers, such as detection limits, signal detection, changing capillary environment, resolution separation of analytes, and hyphenation of mass spectrometry with CE, for a range of analytical problems. Each chapter outlines a specific electrophoretic variant with detailed instructions and some standard operating procedures. In this respect, the book meets its desired goal of rendering assistance to lovers of electrophoresis.Trade Review"Decades after its introduction, capillary electrophoresis has evolved into a mature technique, especially in the field of pharmaceutical analysis. This book focuses on a number of fields in which this separation technique has proven its unique usefulness, such as chiral separations and the analysis of protein biopharmaceuticals. It highlights the current state of the art and offers high-quality general chapters and overviews as well as topical chapters. Recommended reading for all those involved in pharmaceutical analysis, albeit academically or industrially!"—Prof. Ann Van Schepdael, University of Leuven, BelgiumTable of ContentsCapillary Electrophoresis: A Versatile Technique in Pharmaceutical Analysis. Recent Applications of Chiral Capillary Electrophoresis in Pharmaceutical Analysis. A Mini-Review on Enantiomeric Separation of Ofloxacin using Capillary Electrophoresis: Pharmaceutical Applications. Nano-Stationary Phases for Capillary Electrophoresis Techniques. Capillary Electrophoresis Coupled to Mass Spectrometry for Enantiomeric Drugs Analysis. Enantioselective Drug–Plasma Protein-Binding Studies by Capillary Electrophoresis. Clinical Use of Capillary Zone Electrophoresis: New Insights into Parkinson’s Disease. Electrophoretically Mediated Microanalysis for Evaluation of Enantioselective Drug Metabolism. Capillary Electrophoresis for the Quality Control of Intact Therapeutic Monoclonal Antibodies. Molecular Simulation of Chiral Selector–Enantiomer Interactions through Docking: Antimalarial Drugs as Case Study.
£85.50
Jenny Stanford Publishing Nanotechnology and Drug Delivery: Principles and
Book SynopsisThis book presents an overview of the rapidly developing field of nanotechnology applications in drug delivery systems and covers a variety of technologies and materials that help in achieving vast variation in the particle size needed in technology and drug delivery-based research. It discusses nanotechnology’s use in healthcare for the development of target-specific drug therapy and smart field systems and in the pharmaceutical industry to improve the quality, efficacy, and shelf life of medicines. Bringing together principles, theory, practice, and applications of nanotechnology, the book is a useful resource for chemists, physicists, biomedical researchers, engineers, advanced undergraduate and graduate-level students in nanotechnology, researchers in pharmaceutical sciences, chemistry, biology, biotechnology engineering, and general readers in nanotechnology.Table of Contents1. Basics of Nanotechnology and Drug Delivery Systems 2. Regulatory Barriers to the Marketing Authorization of Nanodrug Delivery System 3. Nanodrug Delivery System for Brain Targeting 4. Reconnoitring the Beneficial Role of Nanodrug Delivery System in Treating Cardiovascular Disorders 5. Smart Targeted Novel Nanocarriers-Based Treatment of Arthritis 6. Novel Drug Delivery System for Ocular Target 7. Nanotechnology-Based Drug Delivery Systems for the Treatment of Pulmonary Diseases 8. The Potential of Nanotechnology in Transdermal Drug Delivery Systems 9. Novel Drug Delivery Systems for Infection Treatment 10. Novel Drug Delivery System Approach in Cancer Treatment 11. Nano-Drug Delivery Systems in the Treatment of Wound Healing 12. Nanodrug Delivery Systems for Cosmetics 13. Novel Drug Delivery System for Rectal and Vaginal Targets 14. Nanoneutraceuticals and Their Applications
£146.30
